CN102526540B - Medicinal composition with effect of relieving pain of main and collateral channels - Google Patents

Medicinal composition with effect of relieving pain of main and collateral channels Download PDF

Info

Publication number
CN102526540B
CN102526540B CN 201210075374 CN201210075374A CN102526540B CN 102526540 B CN102526540 B CN 102526540B CN 201210075374 CN201210075374 CN 201210075374 CN 201210075374 A CN201210075374 A CN 201210075374A CN 102526540 B CN102526540 B CN 102526540B
Authority
CN
China
Prior art keywords
weight portion
weight
pharmaceutical composition
rhizoma
medicinal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210075374
Other languages
Chinese (zh)
Other versions
CN102526540A (en
Inventor
刘金鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210075374 priority Critical patent/CN102526540B/en
Publication of CN102526540A publication Critical patent/CN102526540A/en
Application granted granted Critical
Publication of CN102526540B publication Critical patent/CN102526540B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicinal composition with an effect of relieving pain of main and collateral channels. The medicinal composition consists of rehmannia root, murdannia triquetra, cassia bark, tall gastrodia tuber, safflower, common clubmoss herb, incised notopterygium rhizome and Ningpo yam rhizome. The medicinal composition can be prepared into clinically-acceptable decoction, pills, capsules, tablets, granules, powder, oral liquid, medicinal liquor, emplastrum, ointment, spray, liniment or tinctures by adding auxiliary materials based on the conventional process. The medicinal composition has the effects of promoting blood circulation, removing blood stasis and dredging main and collateral channels, has an obvious effect of treating the pain caused by the main and collateral channels, vasospasm, rheumatism or traumatic injury and the like, can relieve the pain instantly and does not have toxic or side effect.

Description

A kind of pharmaceutical composition with meridians analgesic effect
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition with meridians analgesic effect.
Background technology
A kind of common disease symptoms to the pain that causes because of meridians, vasospasm, rheumatism, traumatic injury etc. at present.The people who suffers from this type of disease symptoms is a lot, deeply is subjected to its ailing torment.The medicine of various treatment pain of selling in the market is a lot, but is the Chinese medicine and western medicine combination mostly, and curative effect is not very remarkable, and side effect is also larger, can only play mitigation, can not treating both the principal and secondary aspects of a disease.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition with meridians analgesic effect.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Radix Rehmanniae Preparata 5-15 weight parts water Folium Bambusae 5-15 weight portion Cortex Cinnamomi 5-15 weight portion
Rhizoma Gastrodiae 5-15 weight portion Flos Carthami 5-15 weight portion Herba Lycopodii 5-15 weight portion
Rhizoma Et Radix Notopterygii 5-15 weight portion Rhizoma Dioscoreae Nipponicae 5-15 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 10 weight parts water Folium Bambusaes 10 weight portion Cortex Cinnamomis 10 weight portions
Rhizoma Gastrodiae 10 weight portion Flos Carthamis 10 weight portion Herba Lycopodiis 10 weight portions
Rhizoma Et Radix Notopterygii 10 weight portion Rhizoma Dioscoreae Nipponicae 10 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 7 weight parts water Folium Bambusaes 13 weight portion Cortex Cinnamomis 7 weight portions
Rhizoma Gastrodiae 13 weight portion Flos Carthamis 7 weight portion Herba Lycopodiis 13 weight portions
Rhizoma Et Radix Notopterygii 7 weight portion Rhizoma Dioscoreae Nipponicae 13 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 13 weight parts water Folium Bambusaes 7 weight portion Cortex Cinnamomis 13 weight portions
Rhizoma Gastrodiae 7 weight portion Flos Carthamis 13 weight portion Herba Lycopodiis 7 weight portions
Rhizoma Et Radix Notopterygii 13 weight portion Rhizoma Dioscoreae Nipponicae 7 weight portions.
Pharmaceutical composition of the present invention adds conventional adjuvant according to common process and makes the decoction of clinical acceptance, pill, capsule, tablet, granule, powder, oral liquid, medicated wine, emplastrum, ointment, spray, liniment or tincture.
Pharmaceutical composition of the present invention has blood circulation promoting and blood stasis dispelling, dredging the meridian, and is remarkable to the pain effect that causes because of meridians, vasospasm, rheumatism or traumatic injury etc., and can the moment pain relieving.Have no side effect.
Following experimental example is used for further specifying the present invention, but is not limited to the present invention.
One, experimental example
1, clinical observation
Pain patients 30 examples that medicated wine of the present invention (according to embodiment 1 method preparation) treatment causes because of meridians, vasospasm, rheumatism or traumatic injury etc., male's 15 examples wherein, women's 15 examples.
2, medicament selection
Medicated wine of the present invention (according to the preparation of embodiment 1 method) is treated two courses for the treatment of (7 days courses for the treatment of), painful area is massaged every day 2-3 time with medicated wine of the present invention.
3, diagnostic criteria
Medical history: the pain that causes because of meridians, vasospasm, rheumatism or traumatic injury etc.
Symptom: arthralgia, myalgia, headache, limbs pain etc.Severe pain when movable is met cold aggravation.
4, criterion of therapeutical effect
Draft as follows with reference to " in cure the desease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine 1994 implements:
Recovery from illness: tcm clinical practice symptom, sign disappear or basic the disappearance;
Produce effects: tcm clinical practice symptom, sign obviously change;
Effectively: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign are all without obviously improving;
5, therapeutic outcome
Treatment number (example) Cure Produce effects Effectively Invalid Total effective rate (%)
30 25 3 2 0 100%
6, conclusion
Above-mentioned 30 routine patients all use medicated wine of the present invention (according to the preparation of embodiment 1 method), and massage sore place 2-3 time with medicated wine every day, treats two courses for the treatment of (7 days each courses for the treatment of), and total effective rate reaches 100%.
7, discuss
Radix Rehmanniae Preparata has another name called Radix Rehmanniae Preparata or throws oneself on the ground in the pharmaceutical composition of the present invention, belongs to goatweed, is a kind of first-class Chinese crude drug, has the YIN nourishing of enriching blood effect; The Herba Murdanniae Triquetrae nature and flavor: sweet in the mouth, property is flat, enters liver, spleen two warps, has the effect of heat clearing away, diuresis, detumescence, detoxifcation; It is fiery supporing yang that Cortex Cinnamomi has benefit, let the fire back to its origin, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow.Warming the spleen and stomach, removing accumulated cold, the effect of promoting blood circulation; Rhizoma Gastrodiae has the endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, the effect of dispelling wind and removing obstruction in the collateral; Flos Carthami has the effect of the latus rectum of invigorating blood circulation, eliminating stasis to stop pain, is used for amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury; Herba Lycopodii Latin formal name used at school: rhizome of Whiteback Greenbrier has expelling wind and cold, dehumidifying detumescence, the effect of relaxing muscles and tendons and activating QI and blood in the collateral.All medicine merging have blood circulation promoting and blood stasis dispelling, dredging the meridian, and are remarkable to the pain effect that causes because of meridians, vasospasm, rheumatism or traumatic injury etc., and can the moment pain relieving.Have no side effect.
Experimental example two, model case
Case 1: high so-and-so, woman, 67 years old.Suffered from trigeminal neuralgia 10 years, migraine is cured every day 2-3 time with medicated wine of the present invention (according to the preparation of embodiment 1 method) massage two courses for the treatment of (7 days each courses for the treatment of).
Case 2: Zhu, woman, 16 years old.Suffer from hyperosteogeny, neck is askew, scoliosis can not normally be gone to school, and cures with capsule of the present invention (according to the preparation of embodiment 2 methods) treatment three courses for the treatment of (7 days each courses for the treatment of).
Case 3: Lee, man, 42 years old.Suffer from the rheumatic scapulohumeral periarthritis, the right hand can not be lifted and normal bending the difficulty of having a meal, hurt like hell by height.Cure with ointment of the present invention (according to the preparation of embodiment 3 methods) treatment two courses for the treatment of (7 days each courses for the treatment of).
Case 4: high certain, man, 46 years old.Suffer from cervical spondylosis, headache, dizziness, the impact normal operation is cured with spray of the present invention (according to the preparation of embodiment 4 methods) treatment three courses for the treatment of (7 days each courses for the treatment of).
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1 medicated wine
Radix Rehmanniae Preparata 10g Herba Murdanniae Triquetrae 10g Cortex Cinnamomi 10g
Rhizoma Gastrodiae 10g Flos Carthami 10g Herba Lycopodii 10g
Rhizoma Et Radix Notopterygii 10g Rhizoma Dioscoreae Nipponicae 10g
Said medicine seals infusion 7 days with the Chinese liquor 10kg room temperature of brew, fills with to spraying use in the bottle.With medicated wine 2-3 massage every day affected part.
Embodiment 2 capsules
Radix Rehmanniae Preparata 7kg Herba Murdanniae Triquetrae 13kg Cortex Cinnamomi 7kg
Rhizoma Gastrodiae 13kg Flos Carthami 7kg Herba Lycopodii 13kg
Rhizoma Et Radix Notopterygii 7kg Rhizoma Dioscoreae Nipponicae 13kg
Said medicine is added conventional adjuvant according to common process make capsule.
Embodiment 3 ointments
Radix Rehmanniae Preparata 13kg Herba Murdanniae Triquetrae 7kg Cortex Cinnamomi 13kg
Rhizoma Gastrodiae 7kg Flos Carthami 13kg Herba Lycopodii 7kg
Rhizoma Et Radix Notopterygii 13kg Rhizoma Dioscoreae Nipponicae 7kg
Said medicine is added conventional adjuvant according to common process make ointment.
Embodiment 4 sprays
Radix Rehmanniae Preparata 10kg Herba Murdanniae Triquetrae 10kg Cortex Cinnamomi 10kg
Rhizoma Gastrodiae 10kg Flos Carthami 10kg Herba Lycopodii 10kg
Rhizoma Et Radix Notopterygii 10kg Rhizoma Dioscoreae Nipponicae 10kg
Said medicine is added conventional adjuvant according to common process make spray.
Embodiment 5 tablets
Radix Rehmanniae Preparata 7kg Herba Murdanniae Triquetrae 13kg Cortex Cinnamomi 7kg
Rhizoma Gastrodiae 13kg Flos Carthami 7kg Herba Lycopodii 13kg
Rhizoma Et Radix Notopterygii 7kg Rhizoma Dioscoreae Nipponicae 13kg
Said medicine is added conventional adjuvant according to common process make tablet.
Embodiment 6 liniments
Radix Rehmanniae Preparata 13kg Herba Murdanniae Triquetrae 7kg Cortex Cinnamomi 13kg
Rhizoma Gastrodiae 7kg Flos Carthami 13kg Herba Lycopodii 7kg
Rhizoma Et Radix Notopterygii 13kg Rhizoma Dioscoreae Nipponicae 7kg
Said medicine is added conventional adjuvant according to common process make liniment.

Claims (6)

1. the pharmaceutical composition with meridians analgesic effect is characterized in that, the crude drug of said composition consists of:
Radix Rehmanniae Preparata 5-15 weight parts water Folium Bambusae 5-15 weight portion Cortex Cinnamomi 5-15 weight portion
Rhizoma Gastrodiae 5-15 weight portion Flos Carthami 5-15 weight portion Herba Lycopodii 5-15 weight portion
Rhizoma Et Radix Notopterygii 5-15 weight portion Rhizoma Dioscoreae Nipponicae 5-15 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 10 weight parts water Folium Bambusaes 10 weight portion Cortex Cinnamomis 10 weight portions
Rhizoma Gastrodiae 10 weight portion Flos Carthamis 10 weight portion Herba Lycopodiis 10 weight portions
Rhizoma Et Radix Notopterygii 10 weight portion Rhizoma Dioscoreae Nipponicae 10 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 7 weight parts water Folium Bambusaes 13 weight portion Cortex Cinnamomis 7 weight portions
Rhizoma Gastrodiae 13 weight portion Flos Carthamis 7 weight portion Herba Lycopodiis 13 weight portions
Rhizoma Et Radix Notopterygii 7 weight portion Rhizoma Dioscoreae Nipponicae 13 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 13 weight parts water Folium Bambusaes 7 weight portion Cortex Cinnamomis 13 weight portions
Rhizoma Gastrodiae 7 weight portion Flos Carthamis 13 weight portion Herba Lycopodiis 7 weight portions
Rhizoma Et Radix Notopterygii 13 weight portion Rhizoma Dioscoreae Nipponicae 7 weight portions.
5. such as the described pharmaceutical composition of one of claim 1-4, it is characterized in that this pharmaceutical composition adds conventional adjuvant according to common process and makes the decoction of clinical acceptance, pill, capsule, tablet, granule, powder, oral liquid, medicated wine, emplastrum, ointment, spray, liniment or tincture.
6. has application in the medicine of meridians analgesic effect such as the described pharmaceutical composition of one of claim 1-4 in preparation.
CN 201210075374 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels Expired - Fee Related CN102526540B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210075374 CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210075374 CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Publications (2)

Publication Number Publication Date
CN102526540A CN102526540A (en) 2012-07-04
CN102526540B true CN102526540B (en) 2013-10-23

Family

ID=46335360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210075374 Expired - Fee Related CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Country Status (1)

Country Link
CN (1) CN102526540B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255172C (en) * 2004-08-09 2006-05-10 刘勇成 Medical paste for rheumatism and bone ache
CN100566742C (en) * 2007-08-15 2009-12-09 陈玉龙 The Chinese medicine preparation of treatment hyperosteogeny disease

Also Published As

Publication number Publication date
CN102526540A (en) 2012-07-04

Similar Documents

Publication Publication Date Title
CN102614286A (en) Medicine for treating cold and preparation method for medicine
CN103861046A (en) Traditional Chinese medicine for treating prosopalgia
CN102631512B (en) Traditional Chinese medicine composition for curing chronic colitis
CN104491220A (en) Traditional Chinese medicine composition for treating herpes zoster
CN103784804A (en) Pharmaceutical composition for treating benign prostatic hyperplasia
CN106039225A (en) Traditional Chinese medicine preparation for treating acute lumbar muscle sprain
CN102526540B (en) Medicinal composition with effect of relieving pain of main and collateral channels
CN102727773B (en) Traditional Chinese medicinal capsule for treating blood mucoviscidosis
CN103610831B (en) A kind of Chinese medicine for the treatment of neck and shoulder pain
CN102688451B (en) Chinese medicinal composition for treating alcoholic fatty liver
CN105770796A (en) Medicinal liquor liniment for treating soft tissue injury
CN104887775A (en) Traditional Chinese medicine preparation for treating neonatal scleredema and preparation method therefor
CN104857368A (en) Traditional Chinese medicine composition for treating psoatic strain and preparation method
CN103550620B (en) A kind of externally-applied medicinal composition treating rheumatalgia
CN103330732B (en) Spray agent for treating arthritis
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN102028810B (en) Traditional Chinese medicine for treating lumbar intervertebral disc protrusion
CN101897764A (en) Chinese medicinal preparation for treating sciatica
CN105288528A (en) Medicinal liquor for treating spleen-stomach disharmony
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN104147263A (en) Traditional Chinese medicine for treating neurodermatitis
CN105079392A (en) Preparation for treating ischialgia and preparation method thereof
CN104771528A (en) Traditional Chinese medicine composition for treating urinary calculi
CN102362937B (en) Medicinal composition for treating rheumatic aches and pains
CN103316321B (en) Colitis treatment spray

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131023

Termination date: 20190321